» Articles » PMID: 30805369

Relationships of , , and Gene Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2019 Feb 27
PMID 30805369
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Solute carrier family 2 member 4- (SLC2A4-) retinol binding protein-4- (RBP4-) phosphoenolpyruvate carboxykinase 1 (PCK1)/phosphoinositide 3-kinase (PI3K) is an adipocyte derived "signalling pathway" that may contribute to the pathogenesis of type 2 diabetes mellitus (T2DM). We explored whether single nucleotide polymorphisms (SNPs) of these "signalling pathway" genes are associated with gestational diabetes mellitus (GDM).

Methods: Case-control studies were conducted to compare GDM and control groups. A total of 334 cases and 367 controls were recruited. Seventeen candidate SNPs of the pathway were selected. Chi-square tests, logistic regression, and linear regression were used to estimate the relationships of SNPs with GDM risk and oral glucose tolerance test (OGTT), fasting insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) levels. Model-based multifactor dimensionality reduction was used to estimate the adjusted interactions between genes. Regression and interaction analyses were adjusted by maternal age, prepregnancy BMI, and weekly BMI growth. The Bonferroni correction was applied for multiple comparisons.

Results: rs7091052 was significantly associated with GDM risk. rs5435, rs7091052, rs1042531 and rs2236745, and (coding gene of the PI3K P85 subunit) rs34309 were associated with OGTT, fasting insulin, and HOMA-IR levels in the linear regression analysis. The gene-gene interaction analysis showed that, compared with pregnant women with other genotype combinations, women with rs5435 (CC/CT), rs7091052 (CC), rs1042531 (TT/TG) and rs2236745 (TT), and rs34309 (AA) had lower GDM risk.

Conclusion: , , and genes may be involved in the pathogenesis of GDM.

Citing Articles

Assessment of Changes in the Expression of Genes Involved in Insulin Signaling and Glucose Transport in Leukocytes of Women with Gestational Diabetes During Pregnancy and in the Postpartum Period.

Zieleniak A, Zurawska-Klis M, Laszcz K, Bulash K, Pacyga D, Cypryk K Int J Mol Sci. 2024; 25(23).

PMID: 39684804 PMC: 11641716. DOI: 10.3390/ijms252313094.


Longitudinal integrative cell-free DNA analysis in gestational diabetes mellitus.

Tang Z, Wang S, Li X, Hu C, Zhai Q, Wang J Cell Rep Med. 2024; 5(8):101660.

PMID: 39059385 PMC: 11384941. DOI: 10.1016/j.xcrm.2024.101660.


Genetic and Epigenetic Factors in Gestational Diabetes Mellitus Pathology.

Ustianowski L, Udzik J, Szostak J, Goracy A, Ustianowska K, Pawlik A Int J Mol Sci. 2023; 24(23).

PMID: 38068941 PMC: 10706782. DOI: 10.3390/ijms242316619.


Functionally Significant Variants in Genes Associated with Abdominal Obesity: A Review.

Bairqdar A, Ivanoshchuk D, Shakhtshneider E J Pers Med. 2023; 13(3).

PMID: 36983642 PMC: 10056771. DOI: 10.3390/jpm13030460.


Current Studies on Molecular Mechanisms of Insulin Resistance.

Pei J, Wang B, Wang D J Diabetes Res. 2023; 2022:1863429.

PMID: 36589630 PMC: 9803571. DOI: 10.1155/2022/1863429.


References
1.
Ueki K, Fruman D, Brachmann S, Tseng Y, Cantley L, Kahn C . Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol. 2002; 22(3):965-77. PMC: 133541. DOI: 10.1128/MCB.22.3.965-977.2002. View

2.
Horikawa Y, Yamasaki T, Nakajima H, Shingu R, Yoshiuchi I, Miyagawa J . Identification of a novel variant in the phosphoenolpyruvate carboxykinase gene promoter in Japanese patients with type 2 diabetes. Horm Metab Res. 2003; 35(5):308-12. DOI: 10.1055/s-2003-41307. View

3.
Cao H, Van der Veer E, Ban M, Hanley A, Zinman B, Harris S . Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004; 89(2):898-903. DOI: 10.1210/jc.2003-031361. View

4.
Mueller J . Linkage disequilibrium for different scales and applications. Brief Bioinform. 2004; 5(4):355-64. DOI: 10.1093/bib/5.4.355. View

5.
Brachmann S, Ueki K, Engelman J, Kahn R, Cantley L . Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice. Mol Cell Biol. 2005; 25(5):1596-607. PMC: 549361. DOI: 10.1128/MCB.25.5.1596-1607.2005. View